Ellie Mertens rounds up recent intellectual property news, including the Fourth Circuit's Redskins ruling, the PTAB invalidation of a cancer drug patent, antitrust suits against Allergan, an Eagles trade mark settlement, Google and Tencent’s cross-licence, a Federal Circuit ruling on royalties, LG’s dismissed appeal at the European General Court, a new TPP, an Australian SEP case, Marathon’s blockchain patents acquisition, and Argentina’s implementation of an IP decree
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
As global commerce continues to expand through e-commerce platforms and digital marketplaces, protecting brands has become a growing challenge for organisations worldwide. Counterfeiting, intellectual property infringement, and online brand abuse are increasing across industries, making brand protection strategies a critical priority for businesses.
Henrik Holzapfel and Chuck Larsen of McDermott Will & Schulte explain why a Court of Appeal ruling could promote access to justice and present a growth opportunity for litigation finance